Angiotensin II Receptor Blockers in Pregnancy: A Case Report and Systematic Review of the Literature
The DOI matches its Crossref record; 30 of the 30 references it cites were found in a registry or an index.
Abstract
OBJECTIVE: To describe the case of a woman exposed to angiotensin-II receptor blockers (ARBs) in the preconceptional period and to systematically review the literature on the safety of these drugs when used by pregnant women. METHODS: The case was identified at the Korean Motherisk Program (Seoul). For the systematic review, we searched the PubMed for case reports, case series, and post-marketing surveys. RESULTS: A hypertensive woman was exposed to irbesartan prior to conception. The embryo had delayed development of upper and lower extremities and decreased digital groove. A karyotype identified a 45,XO Turner syndrome. The patient had a spontaneous abortion. Including the case reported here, 64 published cases were identified in total; 57.8% had favorable and 42.2% had unfavorable outcomes. Duration of treatment during pregnancy among women who had adverse fetal outcomes was 26.3 +/- 10.5 weeks (mean +/- SD), compared with 17.3 +/- 11.6 weeks in those who had favorable outcomes (p = 0.04). CONCLUSIONS: Exposure to ARBs for a period longer than the first trimester of pregnancy appears to be associated with a high risk for adverse fetal outcomes.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“This is most proven for use of these drugs during the second and third trimesters (54).”
From Diabetes and Pregnancy: An Endocrine Society Clinical Practice Guideline (2013) · cites this paper as [54]
In the citing paper
“ACE inhibitors (51, 52) and angiotensin-receptor blockers (52, 53) are teratogenic (54).”
From Diabetes and Pregnancy: An Endocrine Society Clinical Practice Guideline (2013) · cites this paper as [53]
Citations
Cites
Lewis, E. J., Hunsicker, L. G., Clarke, W. R., Berl, T., Pohl, M. A., Lewis, J. B., Ritz, E., Atkins, R. C., Rohde, R., & Raz, I. (2001) · New England Journal of Medicine · doi:10.1056/nejmoa011303 · Cited by 5,987
WHO analysis of causes of maternal death: a systematic review
Khan, K. S., Wojdyla, D., Say, L., Gülmezoglu, A. M., & Van Look, P. F. (2006) · The Lancet · doi:10.1016/s0140-6736(06)68397-9 · Cited by 3,978
Developing human : clinically oriented embryology
Moore, K. L., Persaud, T. V. N., & Torchia, M. G. (1973) · UCLA - Biblioteca de Ciencias de la Salud · Cited by 2,299
Major Causes of Death among Men and Women in China
He, J., Gu, D., Wu, X., Reynolds, K., Duan, X., Yao, C., Wang, J., Chen, C.-S., Chen, J., Wildman, R. P., et al. (2005) · New England Journal of Medicine · doi:10.1056/nejmsa050467 · Cited by 1,128
Casas, J. P., Chua, W., Loukogeorgakis, S., Vallance, P., Smeeth, L., Hingorani, A. D., & MacAllister, R. J. (2005) · The Lancet · doi:10.1016/s0140-6736(05)67814-2 · Cited by 745
Weber, M. A., Julius, S., Kjeldsen, S. E., Brunner, H. R., Ekman, S., Hansson, L., Hua, T., Laragh, J. H., McInnes, G. T., Mitchell, L., et al. (2004) · The Lancet · doi:10.1016/s0140-6736(04)16456-8 · Cited by 591
Philipp, T. (2003) · Human Reproduction · doi:10.1093/humrep/deg309 · Cited by 288
Teratogen update: Angiotensin‐converting enzyme inhibitors
Barr, M. (1994) · Teratology · doi:10.1002/tera.1420500606 · Cited by 176
Hypertension in pregnancy: Number 219 - January 1996 (replaces no. 91, February 1986)
(1996) · International Journal of Gynecology & Obstetrics · doi:10.1016/s0020-7292(96)90112-5 · Cited by 169
Chronic hypertension in pregnancy
Haddad, B., & Sibai, B. M. (1999) · Annals of Medicine · doi:10.3109/07853899908995887 · Cited by 167
Research works printed but not linked: 2
- Sibai BM, 2002, Obstet Gynecol, 100, 369, 10.1016/S0029-7844(02)02128-2 · doi:10.1016/s0029-7844(02)02128-2 · Paper page
- Briggs GG, 2001, Ann Pharmacother, 35, 859, 10.1345/aph.1A013 · doi:10.1345/aph.1a013 · Paper page
Cited by
Diabetes and Pregnancy: An Endocrine Society Clinical Practice Guideline
Blumer, I., Hadar, E., Hadden, D. R., Jovanovič, L., Mestman, J. H., Murad, M. H., & Yogev, Y. (2013) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2013-2465 · Cited by 561
“Evidence ACE inhibitors (51, 52) and angiotensin-receptor blockers (52, 53) are teratogenic (54).”
Bullo, M., Tschumi, S., Bucher, B. S., Bianchetti, M. G., & Simonetti, G. D. (2012) · Hypertension · doi:10.1161/hypertensionaha.112.196352 · Cited by 334
Norris, S. L., Kansagara, D., Bougatsos, C., & Fu, R. (2008) · Annals of Internal Medicine · doi:10.7326/0003-4819-148-11-200806030-00008 · Cited by 228
Pregnancy in chronic kidney disease and kidney transplantation
Webster, P., Lightstone, L., McKay, D. B., & Josephson, M. A. (2017) · Kidney International · doi:10.1016/j.kint.2016.10.045 · Cited by 161
Ocaranza, M. P., Moya, J., Barrientos, V., Alzamora, R., Hevia, D., Morales, C., Pinto, M., Escudero, N., García, L., Novoa, U., et al. (2014) · Journal of Hypertension · doi:10.1097/hjh.0000000000000094 · Cited by 99
“AT2R is the predominant Ang II receptor subtype in the fetal and early postnatal period, and the absence of AT2R negatively affect cardiac and renal maturation and growth [35–37].”
Background
Metadata
- Authors
- Velázquez-Armenta, E. Y., Han, J. Y., Choi, J. S., Yang, K. M., & Nava-Ocampo, A. A.
- Affiliations
- Cheil General Hospital and Women's Healthcare Center (KR)
- Venue
- Hypertension in Pregnancy
- Publisher
- Informa UK Limited
- Published
- 2007-01
- Volume
- 26
- Issue
- 1
- Pages
- 51-66
- ISSN
- 1064-1955 (ISSN-L)
- 1525-6065
- OpenAlex
- W2158731325
- Cited by
- 33
- References
- 30
- Citations by year
- 2025: 1 · 2024: 2 · 2022: 1 · 2021: 2 · 2019: 1 · 2018: 2 · 2017: 3 · 2015: 3 · 2014: 4 · 2013: 2 · 2012: 5
- FWCI
- 0.37
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Hypertension in Pregnancy (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Pregnancy and Medication Impact
- Health Sciences › Medicine › Obstetrics and Gynecology › Pregnancy and preeclampsia studies
- Health Sciences › Medicine › Pediatrics, Perinatology and Child Health › Pharmacological Effects and Toxicity Studies
- Keywords
- angiotensin receptor blockers, pregnancy, drug safety, irbesartan, Turner syndrome, miscarriage, fetal malformations, drug exposure duration, first trimester
- MeSH terms
- Abortion, Spontaneous, Irbesartan, Adult, Biphenyl Compounds, Female, Humans, Pregnancy, Pregnancy Outcome, Prenatal Exposure Delayed Effects, Tetrazoles, Time Factors, Turner Syndrome, Angiotensin II Type 1 Receptor Blockers, Preconception Injuries
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Angiotensin II Receptor Blockers in Pregnancy: A Case Report and Systematic Review of the Literature. https://app.cochat.ai/papers/10.1080/10641950601147937
- The paper
- Velázquez-Armenta, E. Y., Han, J. Y., Choi, J. S., Yang, K. M., & Nava-Ocampo, A. A. (2007). Angiotensin II Receptor Blockers in Pregnancy: A Case Report and Systematic Review of the Literature. Hypertension in Pregnancy. https://doi.org/10.1080/10641950601147937
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.